Education
About Us
Working with TipRanks
Follow Us
Kyverna Therapeutics, Inc. (KYTX)
NASDAQ:KYTX
| Dec 24 | Dec 23 | Dec 22 | Dec 21 | |
|---|---|---|---|---|
| Income Statement | ||||
| Total Revenue | $ 0.00 | $ 0.00 | $ 7.03M | $ 5.66M |
| Gross Profit | $ -2.13M | $ -1.71M | $ 7.03M | $ 5.66M |
| Operating Income | $ -142.60M | $ -62.41M | $ -29.38M | $ -26.35M |
| EBITDA | $ -125.20M | $ -58.47M | $ -27.78M | $ -25.76M |
| Net Income | $ -127.48M | $ -60.37M | $ -28.89M | $ -26.35M |
| Balance Sheet | ||||
| Cash & Short-Term Investments | $ 285.98M | $ 57.54M | $ 51.32M | $ 76.07M |
| Total Assets | $ 304.64M | $ 75.19M | $ 66.92M | $ 85.49M |
| Total Debt | $ 8.24M | $ 9.08M | $ 10.56M | $ 5.55M |
| Net Debt | $ -88.38M | $ -25.57M | $ -27.17M | $ -70.51M |
| Total Liabilities | $ 38.06M | $ 26.02M | $ 20.25M | $ 131.74M |
| Stockholders' Equity | $ 266.59M | $ 49.18M | $ 46.68M | $ -46.25M |
| Cash Flow | ||||
| Free Cash Flow | $ -116.45M | $ -53.03M | $ -36.88M | $ -23.44M |
| Operating Cash Flow | $ -114.25M | $ -52.41M | $ -36.11M | $ -22.16M |
| Investing Cash Flow | $ -160.90M | $ -8.79M | $ -14.10M | $ -1.29M |
| Financing Cash Flow | $ 337.11M | $ 58.12M | $ 11.88M | $ 72.52M |